跳至主要内容
临床试验/NCT00906074
NCT00906074已完成不适用

A Multicenter, Surgeon-Matched Case-Control Study of Severe Surgical Site Infections (SSIs) Following Contaminated Or Dirty-infected Abdominal Surgery

Pfizer0 个研究点目标入组 180 人开始时间: 2009年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pfizer
入组人数
180
主要终点
Percentage of Participants Who Showed Clinical Improvement of SSI

研究概览

简要总结

This is an observational study to evaluate the relative importance of the known risk factors for severe surgical site infections (SSIs) on the development of the more severe SSI cases, and to describe the demographic, clinical features, etiology and the management and outcome of patients suffering from severe SSIs in Spain.

详细描述

Case and Control study.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age of or above 18 years.
  • Admitted to a General Surgery Ward for elective or emergency abdominal surgery.
  • Contaminated or dirty-infected surgical procedures.
  • Only for cases, they will have to present symptoms and signs of a surgical site infection (SSI) (within 0-30 days) after abdominal surgery.
  • Only for controls, patients must be free of SSI after 30 days from surgery, regardless of whether they are still in the hospital or being observed as an outpatient in the external clinic.

排除标准

  • Age under 18 years.
  • American Society of Anesthesiologist (ASA) score of 5 or above.
  • Surgical implant in place.
  • Clean or clean-contaminated surgical procedures.

结局指标

主要结局

Percentage of Participants Who Showed Clinical Improvement of SSI

时间窗: Day 0 (day of surgery) up to 30 days post surgery

Clinical improvement of SSI was defined as healed (signs and symptoms of initial infection resolved) or improved (initial signs and symptoms significantly diminished without the appearance of new signs).

Percentage of Participants With Post-surgical Drainage

时间窗: Day 0 (day of surgery) up to 30 days post surgery

Percentage of Participants With Pre-surgical Morbidities

时间窗: Baseline (Pre-surgical)

Morbidities (risk factors) included: neoplasm, tobacco use, body mass index (weight in kilograms divided by height in meters squared \[BMI kg/m2\]) greater than (\>) 30, diabetes mellitus (DM), immunosuppression/ corticosteroids, anemia (hemoglobin \[Hb\] less than (\>) 9 grams per deciliter \[gr/dL\]) or malnutrition (hypoalbuminemia).

Percentage of Participants Who Received Pre-surgical Antibiotic Prophylaxis

时间窗: Baseline (Pre-surgical)

Percentage of Participants Who Underwent Emergency Surgery or Scheduled Surgery

时间窗: Day 0 (day of surgery)

Percentage of Participants With Classification of Risk of Surgical Infection of Clean-contaminated, Contaminated or Dirty

时间窗: Day 0 (day of surgery)

Surgical infection risk class: Clean-contaminated: controlled entry in normally colonized body cavities/no unusual contamination/minimum fluid discharge/minimal sterile technique violation/re-surgery on clean surgical incision within 7 days/negative surgical exploration through intact skin. Contaminated: no acute inflammation/purulent discharge/significant fluid/material violation of sterile technique/penetrating trauma less than 4 hours old/graft in chronic skin wounds. Dirty: pus-abscess drainage/ preoperatively colonized body cavity perforated/penetrating trauma more than 4 hours old.

Type of Surgeon

时间窗: Day 0 (day of surgery)

Surgical speciality of physician who performed surgery.

Percentage of Participants With Infection

时间窗: Day 0 (day of surgery) up to 30 days post surgery

Microorganism infection by bacterial type.

次要结局

  • Percentage of Participants Whose National Nosocomial Infection Surveillance System (NNISS) Scores of Preoperative Risk of Infection Were Greater Than >0(Baseline (pre-surgical))
  • ASEPSIS Classification in Participants With Serious SSI(Up to 30 days post surgery)
  • Classification of SSI Infection(Day 0 (day of surgery) up to 30 days post surgery)
  • Percentage of Participants Who Had Microbiologic Resolution of SSI (Sensitivity of Microorganisms to Antibiotics)(Day 0 (day of surgery) up to 30 days post surgery)
  • Number of Participants With Antimicrobial Resistance(Day 0 (day of surgery) up to 30 days post surgery)

研究者

发起方
Pfizer
申办方类型
Industry
责任方
Sponsor

相似试验